SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-21-000045
Filing Date
2021-06-17
Accepted
2021-06-17 17:25:56
Documents
15
Period of Report
2021-06-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20210611.htm   iXBRL 8-K 41045
2 EX-99.1 xlrn-20210611xform8kxex991.htm EX-99.1 55172
6 image_0a.jpg GRAPHIC 9993
7 image_1a.jpg GRAPHIC 69643
  Complete submission text file 0001280600-21-000045.txt   355949

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20210611.xsd EX-101.SCH 1948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20210611_lab.xml EX-101.LAB 24275
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20210611_pre.xml EX-101.PRE 12672
8 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20210611_htm.xml XML 10757
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 211025926
SIC: 2836 Biological Products, (No Diagnostic Substances)